Visual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults - Scorecard - MDSpire

Visual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults

  • By

  • Charlotte E. Joslin

  • Angie Wang

  • David J. Lee

  • Lawrence J. Ulanski

  • Byron L. Lam

  • Thasarat S. Vajaranant

  • Carlos E. Mendoza-Santiesteban

  • Michael L. Stewart

  • Giselle Gutierrez Savoy

  • Mehmet Cem Mocan

  • Franklyn Gonzalez

  • D. Diane Zheng

  • Bharat Thyagarajan

  • Laura Coco

  • Amber Pirzada

  • Jianwen Cai

  • Martha L. Daviglus

  • SOL Ojos Study Group

  • Giselle A. Gutierrez Savoy

  • Heather Pauls Hrynyk

  • Angie Wang

  • Raiza Perez Lucena

  • Chunyu Guo

  • Evelyn Ramirez

  • Patrizia A. Chavero

  • Lucila Suarez

  • Banelly Mora

  • Sydney Tobias

  • Manishi A. Desai

  • Pathik P. Amin

  • Hannah Yoon

  • Charles W. Kinnaird

  • Ramón A. Durazo-Arvizu

  • Margaret Weiss

  • Norma Del Risco

  • David J. Lee

  • Stephanie Negron

  • Byron Lam

  • Diane Zheng

  • Neil Schneiderman

  • Laura A. McClure

  • Miguel Valladares Regalado

  • Tamara Juvier-Riesgo

  • Liliana Rosello-Rodriguez

  • Estefania Ruano-Herreria

  • Maia Junco

  • Diana Hernandez Payano

  • Richard Ramos

  • Eliseo Moreno Perez

  • Maria Cristina Buhl

  • Jianwen Cai

  • Franklyn Gonzales

  • Marston Youngblood Jr.

  • Maryann Redford

  • Jimmy T. Le

  • Karla Zadnik

  • Juan E. Grunwald

  • Henry D. Jampel

  • Aracely Rosales

  • Brisa N. Sánchez

  • Sheila K. West

  • Siew Wei Gavin Tan

  • Yi Chong Teo

  • Haslina Hamzah

  • Shu Chin Serene Sim

  • Amalia Juhari

  • Muhamad Asri Abdul Kadir

  • Raudhah Hanim Mohamed Yusof

  • Xingxiu Ho

  • Jinyi Ho

  • Nishal Banu Makdoom

  • Kayathri Jaya Paul

  • Sharifah Athirah Diba Sagoff

  • June 12, 2026

  • 0 min

Share

Clinical Scorecard: Cardiovascular Risk Factors and Visual Impairment Among Hispanic and Latino Adults

At a Glance

CategoryDetail
ConditionVisual Impairment (VI)
Key MechanismsAssociated with cardiovascular disease (CVD) risk factors such as diabetes, hypertension, smoking, obesity, and hypercholesterolemia.
Target PopulationHispanic and Latino adults aged 40 years or older.
Care SettingCommunity-based cohort study in urban US locations (Bronx, Chicago, Miami, San Diego).

Key Highlights

  • Approximately 7 million people in the US are affected by visual impairment.
  • High prevalence of VI observed in US Hispanic/Latino populations.
  • Study analyzes associations between CVD risk factors and VI.
  • VI defined as visual acuity less than or equal to 20/40.
  • Data collected from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Guideline-Based Recommendations

Diagnosis

  • Visual acuity assessed using electronic ETDRS protocols.
  • VI defined by habitual and best-corrected visual acuity.

Management

  • Address CVD risk factors through lifestyle modifications and medical management.

Monitoring & Follow-up

  • Regular eye examinations and monitoring of CVD risk factors.

Risks

  • Increased VI prevalence associated with cumulative CVD risk factors.

Patient & Prescribing Data

Hispanic/Latino adults aged 40 years or older.

Management of CVD risk factors may reduce VI prevalence.

Clinical Best Practices

  • Utilize comprehensive eye examinations for early detection of VI.
  • Implement culturally tailored interventions for Hispanic/Latino populations.

Related Resources & Content

Original Source(s)

Visual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults

  • by Charlotte E. Joslin, Angie Wang, David J. Lee, Lawrence J. Ulanski, Byron L. Lam, Thasarat S. Vajaranant, Carlos E. Mendoza-Santiesteban, Michael L. Stewart, Giselle Gutierrez Savoy, Mehmet Cem Mocan, Franklyn Gonzalez, D. Diane Zheng, Bharat Thyagarajan, Laura Coco, Amber Pirzada, Jianwen Cai, Martha L. Daviglus, SOL Ojos Study Group, Giselle A. Gutierrez Savoy, Heather Pauls Hrynyk, Angie Wang, Raiza Perez Lucena, Chunyu Guo, Evelyn Ramirez, Patrizia A. Chavero, Lucila Suarez, Banelly Mora, Sydney Tobias, Manishi A. Desai, Pathik P. Amin, Hannah Yoon, Charles W. Kinnaird, Ramón A. Durazo-Arvizu, Margaret Weiss, Norma Del Risco, David J. Lee, Stephanie Negron, Byron Lam, Diane Zheng, Neil Schneiderman, Laura A. McClure, Miguel Valladares Regalado, Tamara Juvier-Riesgo, Liliana Rosello-Rodriguez, Estefania Ruano-Herreria, Maia Junco, Diana Hernandez Payano, Richard Ramos, Eliseo Moreno Perez, Maria Cristina Buhl, Jianwen Cai, Franklyn Gonzales , Marston Youngblood Jr., Maryann Redford, Jimmy T. Le, Karla Zadnik, Juan E. Grunwald, Henry D. Jampel, Aracely Rosales , Brisa N. Sánchez, Sheila K. West, Siew Wei Gavin Tan, Yi Chong Teo, Haslina Hamzah, Shu Chin Serene Sim, Amalia Juhari, Muhamad Asri Abdul Kadir, Raudhah Hanim Mohamed Yusof, Xingxiu Ho, Jinyi Ho, Nishal Banu Makdoom, Kayathri Jaya Paul, Sharifah Athirah Diba Sagoff

  • June 12, 2026

Related Content

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Update on Diabetic Disease

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.